Interferon treatment for multiple sclerosis patients in Hong Kong.
We report on nine patients with multiple sclerosis who had received interferon beta-1a treatment for 6 months or more. Seven patients were Chinese and two were Caucasian. Seven patients had the relapsing-remitting type of multiple sclerosis, one had the primary-progressive type, and one had the progressive-relapsing type. Among the six compliant patients with the relapsing-remitting type of disease, four had less frequent relapses after treatment. This study could not show whether or not the use of interferon beta-1a was beneficial to non-compliant patients, or patients with other types of multiple sclerosis.
Lau
K K
KK
Department of Medicine, Princess Margaret Hospital, Kwai Chung, Hong Kong.
Lee
P O
PO
Chan
K Y
KY
Chan
Y W
YW
Chin
K F
KF
D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use*; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy*
D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a